SCHEMBL6133608

SCHEMBL6133608

CC(C)n1nc(-c2sc(Nc3ccccc3)nc2-c2ccccc2)ccc1=O

nearest known ligand 0.48

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
MEN1 O00255 7/20 0.48
KMT2A Q03164 7/20 0.48
GAA P10253 4/20 0.48
MAPT P10636 4/20 0.48
NPC1 O15118 3/20 0.48
RAB9A P51151 3/20 0.48
ALDH1A1 P00352 3/20 0.48
TP53 P04637 2/20 0.48
LMNA P02545 2/20 0.48
NFKB1 P19838 2/20 0.48
NFKB2 Q00653 2/20 0.48
RELA Q04206 2/20 0.48
MERTK Q12866 1/20 0.44
PTGDR2 Q9Y5Y4 2/20 0.43
SMN1; SMN2 Q16637 2/20 0.43
ADORA2B P29275 1/20 0.43
JUN P05412 3/20 0.42
DHODH Q02127 1/20 0.42
XIAP P98170 1/20 0.41
CASP3 P42574 1/20 0.41

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
Bromide SCHEMBL6828822 0.99 MEN1 (0.47) MEN1KMT2AGAAMAPTNPC1
SCHEMBL6135662 0.91 MAPT (0.40) MEN1KMT2AGAAMAPTNPC1
SCHEMBL6134240 0.91 KMT2A (0.47) MEN1KMT2AGAAMAPTNPC1
SCHEMBL6134205 0.89 XIAP (0.43) MEN1KMT2AMAPTALDH1A1TP53
SCHEMBL6133401 0.88 XIAP (0.42) MEN1KMT2AMAPTALDH1A1TP53
Bromide SCHEMBL6134102 0.88 XIAP (0.42) MEN1KMT2AMAPTALDH1A1TP53
SCHEMBL6134187 0.87 XIAP (0.41) MEN1KMT2AMAPTALDH1A1TP53
SCHEMBL6133757 0.86 ADORA1 (0.43) MEN1KMT2AGAAMAPTNPC1
SCHEMBL6133532 0.86 PTGS2 (0.44) GAAMAPTALDH1A1TP53JUN
SCHEMBL6133609 0.86 XIAP (0.43) MEN1KMT2AMAPTALDH1A1TP53

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20050004134-A1 Thiazole derivative and pharmaceutical use thereof ASTELLAS PHARMA INC. (JP) 2005-01-06 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20050004134-A1 Thiazole derivative and pharmaceutical use thereof MC2R, CYP2C9, OXTR MEN1 2508/4885KMT2A 2724/4885GAA 2851/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.